Active, Not Recruiting
A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma
NCT05535244
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Colorado Aurora, Colorado, United States
- Mayo Clinic-Jacksonville Jacksonville, Florida, United States
- University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States